First Class Post-Graduate Degree in Biotechnology / Biochemistry from any recognized University. The candidate must have two years of documented research experience in Mammalian cell culture, Bio imaging and Biochemical assays.
Graduates with degree in Biosciences (Food science. Nutrition, Microbiology, Biotechnology or Biochemistry). Candidate should have previous experience in nutrition and understand regulatory environment / fortification. PGIMER
Develop cost-effective, high-quality, and eco-friendly processes as per ICH guidelines. Optimize lab processes, validate products, and transfer technology to pilot plant.
Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., a global innovation led healthcare company, announced positive topline results from the pivotal EPICS-III Phase 2(b)/3 clinical trial.
The Ministry of Health & Family Welfare through National Rabies Control Program (NRCP) is undertaking strengthening of surveillance of all animal bites in all States/UTs. Data on dog and other animal bite cases and related deaths are reported by all States/UTs, through Integrated Health Information Platform
Shri Amit Agrawal, Secretary, Department of Pharmaceuticals, highlighted Indias transformation into an emerging hub for medical technology at the 17th CII Global MedTech Summit, themed Innovating for a Healthier Future – Advancing MedTech for Global Impact: Make in India, Make for the World, in New Delhi.
The Subject Expert Committee Oncology, in its 25th meeting held at CDSCO headquarters, has recommended granting permission to Bayer Pharmaceuticals Pvt. Ltd. for the manufacture and marketing of Darolutamide Film-Coated Tablets 300 mg in India.
Positive full results from the BaxHTN Phase III trial showed AstraZeneca baxdrostat, demonstrated a statistically significant and clinically meaningful reduction in mean seated systolic blood pressure (SBP) at two doses 2mg and 1mg compared with placebo at 12 weeks. Results were seen in patients with hard-to-control uncontrolled and resistant hypertension who received baxdrostat or placebo on top of standard of care.
M.Sc or M.Pharm in Chemical, Pharma and Life Sciences. candidate with experience in synthetic organic chemistry OR computational chemistry at Central Drug Research Institute
Diploma in Pharmacy. Candidate must be registered with State Pharmacy Council /Pharmacy Council of India. IISCO Steel Plant, a unit of Steel Authority of India Limited, SAIL.
Bachelors/Masters in sciences/Life Sciences /Chemical Engineering. The project focuses on pilot scale demonstration of direct capture carbon dioxide from air using various equipments designed especially for the same.
M.Pharm / M.S. Pharmacology. It is preferred to have experience related to clinical studies, Pre-clinical studies and formulation development. Y. B. Chavan College of Pharmacy
Ph.D. in Biomedical / Life/ Health sciences with thesis in health systems research using qualitative or mixed methods research. Translational Health Science and Technology Institute THSTI